Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells.

Abstract:

:The abnormal Antithrombin-III (AT-III) Toyama has no ability to interact with heparin in the mast cells or heparin-like glycosaminoglycans on the surface of vascular endothelial cells, so that it has low heparin cofactor activity. In the present study, we have measured the binding capacity of 125I-labeled AT-III to cultured porcine aortic endothelial cells and estimated the inactivation of thrombin by AT-III in the presence of endothelial cells. The abnormal AT-III Toyama had low binding capacity to endothelial cells and had lower heparin cofactor antithrombin activity in the presence of endothelial cells than that of normal AT-III. Our results suggested that heparin-like glycosaminoglycans on endothelial cells play as important a role as heparin does in the regulation of antithrombin activity.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Saito S,Takahashi K,Sakuragawa N

doi

10.1016/0049-3848(88)90170-3

subject

Has Abstract

pub_date

1988-04-01 00:00:00

pages

19-25

issue

1

eissn

0049-3848

issn

1879-2472

pii

0049-3848(88)90170-3

journal_volume

50

pub_type

杂志文章
  • The effect of myelin basic protein on the endogenous phosphorylation of platelets.

    abstract::Bovine myelin basic protein (BP) induced a shape change and endogenous phosphorylation of a 45,000 (45K) molecular weight protein of intact human platelets. This effect occurred rapidly over an effective concentration range of 5-100 microM BP. BP peptides encompassing residues 1-42, 43-88, and 89-169 from the BP molec...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90090-1

    authors: Chiang TM,Whitaker JN,Kang AH,Beachey EH

    更新日期:1982-03-15 00:00:00

  • Factor VIII coagulant moiety binds to platelets by binding to phospholipids of the platelet membrane.

    abstract::Washed human platelets were incubated with commercial factor VIII concentrate, or with purified factor VIII coagulant moiety. Platelets were then washed again and lysed by sonication. VIII:Ag and vWf:Ag were measured in the platelet lysate prior to and after incubation of the lysate with phospholipase C (PL-C). Platel...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90223-4

    authors: Muntean W,Leschnik B,Haas J

    更新日期:1987-02-15 00:00:00

  • Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.

    abstract::Selective serotonin reuptake inhibitors (SSRIs) have been reported to reduce platelet aggregation induced by ADP. ADP induces platelet aggregation through two purinergic receptors P2Y1 and P2Y12. We characterized the inhibitory properties of SSRIs on ADP-induced platelet aggregation and investigated the effects of SSR...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.02.007

    authors: Tseng YL,Chiang ML,Lane HY,Su KP,Lai YC

    更新日期:2013-04-01 00:00:00

  • The presence of gamma' chain impairs fibrin polymerization.

    abstract:INTRODUCTION:A fraction of fibrinogen molecules contain an alternatively spliced variant chain called gamma'. Plasma levels of this variant have been associated with both myocardial infarction and venous thrombosis. Because clot structure has been associated with cardiovascular risk, we examined the effect of gamma' ch...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.11.016

    authors: Gersh KC,Nagaswami C,Weisel JW,Lord ST

    更新日期:2009-07-01 00:00:00

  • Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan.

    abstract:BACKGROUND:Clopidogrel, cilostazol, and aspirin were compared in terms of efficacy and safety for primary prevention of stroke in peripheral artery disease (PAD) patients. METHODS:This retrospective cohort study analyzed data contained in the Taiwan National Health Insurance Bureau database for patients treated for PA...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.01.036

    authors: Lee WH,Chu CY,Hsu PC,Su HM,Lin TH,Voon WC,Lai WT,Sheu SH

    更新日期:2013-08-01 00:00:00

  • A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

    abstract:INTRODUCTION:The contribution of platelet activation to the pathogenesis of sickle cell disease (SCD) remains uncertain. We evaluated the safety and efficacy of eptifibatide, a synthetic peptide inhibitor of the αIIbβ3 receptor, in SCD patients during acute painful episodes. MATERIALS AND METHODS:In this single site, ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2013.08.002

    authors: Desai PC,Brittain JE,Jones SK,McDonald A,Wilson DR,Dominik R,Key NS,Parise LV,Ataga KI

    更新日期:2013-09-01 00:00:00

  • Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data.

    abstract:BACKGROUND:Administrative data can be used to identify venous thromboembolism (VTE) and major bleeding (MB) events. However, the validity of this data in emergency room discharge records in Canada is unknown. METHODS:We conducted a single-institution retrospective chart re-abstraction study in London, Canada. We ident...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2015.10.035

    authors: Al-Ani F,Shariff S,Siqueira L,Seyam A,Lazo-Langner A

    更新日期:2015-12-01 00:00:00

  • Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.

    abstract::18F-Fluorodesoxyglucose Positron-Emission-Tomography combined with Computed-Tomography (FDG PET/CT) might be an attractive tool for cancer screening in patients with venous thromboembolism (VTE), allowing non-invasive whole-body imaging. One of the frequent criticisms to the use of FDG PET/CT for screening is the pote...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2017.04.022

    authors: Robin P,Le Roux PY,Le Moigne E,Planquette B,Prévot-Bitot N,Roy PM,Pastre J,Merah A,Couturaud F,Le Gal G,Salaun PY

    更新日期:2017-07-01 00:00:00

  • Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy.

    abstract::The complex relation between thrombotic thrombocytopenic purpura (TTP) and pregnancy is concisely reviewed. Pregnancy is a very strong trigger for acute disease manifestation in patients with hereditary TTP caused by double heterozygous or homozygous mutations of ADAMTS13 (ADisintegrin And Metalloprotease with Thrombo...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/S0049-3848(15)50437-4

    authors: von Auer C,von Krogh AS,Kremer Hovinga JA,Lämmle B

    更新日期:2015-02-01 00:00:00

  • Heavy menstrual bleeding: An update on management.

    abstract::Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss (MBL) >80 mL per cycle, that interferes with a woman's physical, emotional, social wellbeing and quality of life. Aetiology is due to underlying uterine pathologies, coagulopathy, ovulation dysfunction, or iatrogenic. Up to 20% of women with H...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/S0049-3848(17)30072-5

    authors: Davies J,Kadir RA

    更新日期:2017-03-01 00:00:00

  • Inhibitory effect of sodium salicylate on ADP-induced platelet aggregation and on 45Ca2+ uptake into platelets.

    abstract::The effects of sodium salicylate (SS) on ADP-induced platelet aggregation and on a metabolism of calcium in platelets were studied, using gel-filtrated platelets (GFP). SS inhibited dose-responsively ADP-induced aggregation in the presence of fibrinogen and Ca2+. It was found that extracellular 45Ca2+ was rapidly take...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(85)90232-4

    authors: Irino O,Saitoh K,Ohkubo K,Hashimoto S

    更新日期:1985-08-01 00:00:00

  • Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism.

    abstract:INTRODUCTION:Although recurrent venous thromboembolism is a known risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), the prevalence of CTEPH after recurrent pulmonary embolism (PE) is not clear. MATERIALS AND METHODS:A cohort screening study was performed to clarify the prevalence of echocardiograp...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2011.07.045

    authors: Berghaus TM,Barac M,von Scheidt W,Schwaiblmair M

    更新日期:2011-12-01 00:00:00

  • Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.

    abstract:BACKGROUND:Many heparin-induced thrombocytopenia (HIT) antibodies cause platelet activation in the serotonin release assay (SRA) in the absence of heparin. This in vitro observation may help unravel the mechanism of delayed-onset HIT, where seropositive patients develop thrombocytopenia and associated thrombosis after ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.10.021

    authors: Prechel MM,Jeske WP,Walenga JM

    更新日期:2010-04-01 00:00:00

  • Combined occurrence of a heterozygous missense mutation in the protein C gene and allelic exclusion of one protein S allele leading to severe venous thrombosis.

    abstract::Individuals with more than one defect in the natural anticoagulant system exhibit an increased risk for thrombosis. We report on a family with two cases of combined protein C (PROC) and protein S (PROS) deficiency, five cases of isolated PROC deficiency Type I, and two cases of isolated PROS deficiency Type I. PROC an...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00232-8

    authors: Knoll B,Hach-Wunderle V,Rieger S,Häring D,Mannhalter C

    更新日期:2001-07-01 00:00:00

  • Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis.

    abstract::An in vivo rabbit model of venous thrombosis which includes physiological blood flow was used to compare the efficacy of the potent and specific factor Xa inhibitor recombinant tick anticoagulant peptide (rTAP) with standard heparin in the prevention of venous thrombus formation. In anesthetized rabbits, an autologous...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(93)90200-8

    authors: Fioravanti C,Burkholder D,Francis B,Siegl PK,Gibson RE

    更新日期:1993-08-15 00:00:00

  • Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.

    abstract::There is growing evidence on the superior efficacy and safety of low molecular weight heparins (LMWHs) over unfractionated heparin (UFH) for the treatment of both venous and arterial thromboembolism. Heparin exerts its function by potentiating antithrombin and by mobilizing tissue factor pathway inhibitor (TFPI) into ...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(98)00079-6

    authors: Hansen JB,Sandset PM

    更新日期:1998-08-15 00:00:00

  • Obligatory role of lipid mediators in platelet-neutrophil adhesion.

    abstract::Platelet-neutrophil interactions play an important role in thrombotic and inflammatory responses. Although it is well known that adhesion of platelets to neutrophils requires interactions of adhesion molecules on platelets such as P-selectin, or GPIIb/IIIa with their counterparts on neutrophils, little is known on the...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(03)00413-4

    authors: Chlopicki S,Lomnicka M,Gryglewski RJ

    更新日期:2003-06-15 00:00:00

  • The effect of operation and subcutaneous heparin on plasma levels of antithrombin-III.

    abstract::Plasma antithrombin III (AT-III) levels were measured in 61 patients undergoing general surgery. The patients were randomly allocated to a test or a control group. The test group received 5000iu of subcutaneous heparin two hours before operation and then twelve hourly for seven days. The control group received subcuta...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0049-3848(86)90102-7

    authors: Harbourne T,Nicolaides AN

    更新日期:1986-09-15 00:00:00

  • Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer.

    abstract:INTRODUCTION:Plasminogen activator inhibitor (PAI-1) may have an independent prognostic value in breast cancer (BC). PAI-1 4G/5G polymorphism may have significance for antigen expression. Thus, we analyzed the possible associations between PAI-1 4G/5G polymorphism, plasma PAI-1 levels, and clinicopathological features ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.02.014

    authors: Palmirotta R,Ferroni P,Savonarola A,Martini F,Ciatti F,Laudisi A,Sini V,Del Monte G,Guadagni F,Roselli M

    更新日期:2009-09-01 00:00:00

  • Lonofibrase, a novel alpha-fibrinogenase from Lonomia obliqua caterpillars.

    abstract::Envenomation caused by Lonomia obliqua caterpillars is an increasing problem in Southern Brazil. The clinical profile is characterized by a profound hemorrhagic disorder. In the present study, we describe the characterization of a fibrin(ogen)olytic factor (lonofibrase) isolated from a venomous secretion of the caterp...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.01.012

    authors: Pinto AF,Dobrovolski R,Veiga AB,Guimarães JA

    更新日期:2004-01-01 00:00:00

  • Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide.

    abstract::DMP 728 is a potent and specific platelet GPIIb/IIIa antagonist. Like all GPIIb/IIIa antagonists, DMP 728 has a steep dose-response relationship in inhibiting platelet aggregation. In this study the relationships between receptor occupancy, platelet aggregation and bleeding time was determined in anesthetized dogs aft...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)00029-1

    authors: Tsao PW,Bozarth JM,Jackson SA,Forsythe MS,Flint SK,Mousa SA

    更新日期:1995-03-15 00:00:00

  • Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis.

    abstract:INTRODUCTION:Reports on the prevalence and risk factors of atherothrombotic events (AEs) are conflicting in persons with hemophilia (PWH). METHODS:This study evaluated the prevalence and risk factors of AEs among 1054 male hemophilia patients, using data collected from Taiwan's National Health Insurance Research Datab...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.12.027

    authors: Wang JD,Chan WC,Fu YC,Tong KM,Chang ST,Hwang WL,Lin CH,Tsan YT

    更新日期:2015-03-01 00:00:00

  • The role of prothrombotic mutations in patients with Buerger's disease.

    abstract::Thromboangiitis obliterans (TAO), or Buerger's disease, is a segmental occlusive inflammatory disorder of the arteries and veins, and etiopathogenesis is still obscure. In the present study we investigated the prevalence of prothrombin 20210 G-->A, factor V 1691 G-->A (Factor V Leiden), and factor V 4070 A-->G (His 12...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00310-8

    authors: Avcu F,Akar E,Demirkiliç U,Yilmaz E,Akar N,Yalçin A

    更新日期:2000-11-01 00:00:00

  • Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein.

    abstract::Activation of human platelets by PAF was augmented by C-reactive protein, an acute phase plasma protein. The concentration of PAF required for irreversible activation (secondary aggregation of platelet and release of serotonin) was decreased to 1/10 in the presence of C-reactive protein (CRP). The presence of CRP stim...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90361-0

    authors: Kohayakawa M,Inoue K

    更新日期:1986-03-01 00:00:00

  • CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators.

    abstract::Fractalkine/CX3CR1 pathway is considered a major modulator of atherosclerosis. In the present study, expression of CX3CR1 on PBMCs/monocytes of healthy individuals and coronary artery diseased patients was initially assessed by flow cytometry. Effects of pre-inflammatory cytokines interferon (INF)-gamma and tumor necr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2007.04.005

    authors: Apostolakis S,Krambovitis E,Vlata Z,Kochiadakis GE,Baritaki S,Spandidos DA

    更新日期:2007-01-01 00:00:00

  • Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.

    abstract:BACKGROUND AND OBJECTIVE:According to US Food and Drugs Administration (FDA), 2 hour recombinant tissue plasminogen activator (rt-PA) 100mg infusion is recommended for eligible patients with acute pulmonary embolism (PE). However,there exists evidence implying that a lower dosage of rt-PA can be equally effective but p...

    journal_title:Thrombosis research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.thromres.2013.12.026

    authors: Zhang Z,Zhai ZG,Liang LR,Liu FF,Yang YH,Wang C

    更新日期:2014-03-01 00:00:00

  • EUHASS: The European Haemophilia Safety Surveillance system.

    abstract::Pharmacovigilance is an essential element of any drug treatment and considering the history of adverse events due to products used to treat inherited bleeding disorders, it should be an integral component of modern haemophilia treatment. Because inherited bleeding disorders and adverse events are rare, a multicentre, ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/S0049-3848(10)70150-X

    authors: Makris M,Calizzani G,Fischer K,Gilman EA,Hay CR,Lassila R,Lambert T,Ludlam CA,Mannucci PM

    更新日期:2011-01-01 00:00:00

  • Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

    abstract:INTRODUCTION:Ticagrelor and prasugrel are recommended as first line therapy in patients with acute coronary syndromes (ACS). However, patients with anemia are commonly treated with clopidogrel in routine clinical practice. The RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infar...

    journal_title:Thrombosis research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.thromres.2018.05.024

    authors: Guerrero C,Garay A,Ariza-Solé A,Formiga F,Raposeiras-Roubín S,Abu-Assi E,D'Ascenzo F,Kinnaird T,Manzano-Fernández S,Alegre O,Sánchez-Salado JC,Lorente V,Templin C,Velicki L,Xanthopoulou I,Cerrato E,Rognoni A,Boccuzzi G

    更新日期:2018-07-01 00:00:00

  • Purification and characterization of a serine protease with fibrinolytic activity from the dung beetles, Catharsius molossus.

    abstract::Catharsius protease-1 (CPM-1) was isolated from the whole body of the dung beetles, Catharsius molossus, using three purification steps (ammonium sulfate fractionation, gel filtration on Bio-Gel P-60, and affinity chromatography on DEAE Affi-Gel Blue gel). The purified CPM-1 that has a molecular weight of 27 kDa was a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.01.005

    authors: Ahn MY,Hahn BS,Ryu KS,Kim JW,Kim I,Kim YS

    更新日期:2003-01-01 00:00:00

  • Tranexamic acid--an old drug still going strong and making a revival.

    abstract::Experience with tranexamic acid, an indirect fibrinolytic inhibitor, started as soon as it was released from Shosuke Okamoto's lab in the early 1960s. It was first prescribed to females with heavy menstrual blood loss and to patients with hereditary bleeding disorders. Soon the indications were widened to elective sur...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2014.11.012

    authors: Tengborn L,Blombäck M,Berntorp E

    更新日期:2015-02-01 00:00:00